Natus Medical entered into an agreement to acquire GN Otometrics from GN Store Nord in an all cash transaction for $145 million.

JPMorgan Chase and Citibank will provide a $150 million revolving credit facility to support the transaction.

With annual revenue of approximately $110 million, Otometrics is a manufacturer of hearing diagnostics and balance assessment equipment, disposables and software.

“Otometrics has several leading brands and has introduced many industry firsts,” said Jim Hawkins, president and CEO of Natus. “With the addition of Otometrics, we anticipate Natus revenue in 2017 will reach $500 million, a major milestone for the company. We expect Otometrics to be accretive to our 2017 earnings with a non-GAAP contribution operating margin goal for the year of 10% and a 2018 goal of 20%.”

The transaction is expected to close by the end of 2016.